DRAP clarifies SRO 1688 on industry concerns
ISLAMABAD:Drug Regulatory Authority of Pakistan (DRAP) has issued a clarification letter on SRO 1688 following consultations with the Nutraceutical Manufacturers Association of Pakistan (NMAP) to address regulatory ambiguities and concerns raised by t…
Read More